NCR1 and neoplasm: Among others, germline-encoded activating receptors, such as KLRK1 (also known as NKG2D) and the Natural cytotoxicity receptors (NCRs), such as NKp46 (NCR1), NKp44 (NCR2), and NKp30 (NCR3), can synergize to overcome inhibitory thresholds and evoke NK cell anti-tumor functions (26–28).